Mannkind Corp. (MNKD) has provided an update.
MannKind Corporation is set for a leadership transition as Steven B. Binder steps down from his role as CFO and principal accounting officer, to be succeeded by Christopher Prentiss on April 22, 2024. Prentiss brings extensive financial experience from his previous senior roles at ADARx Pharmaceuticals and Adamas Pharmaceuticals. His new compensation package includes a $460,000 base salary, potential for a 50% bonus, relocation assistance, and participation in the equity incentive plan with a significant stock unit award. Prentiss also secures a Change of Control Agreement that provides substantial benefits in case of involuntary termination post a company takeover.
For a thorough assessment of MNKD stock, go to TipRanks’ Stock Analysis page.
